Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nils Pørksen"'
Publikováno v:
Diabetes Care. 25:342-346
OBJECTIVE—Repaglinide, a novel antidiabetic agent that has a rapid onset and short duration of action, was developed for mealtime dosing. The purpose of this pharmacodynamic study was to validate a prandial regimen of repaglinide by comparing meal-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ec3eb5072c03712d0d74b2b68293a0f
https://doi.org/10.2337/diacare.25.2.342
https://doi.org/10.2337/diacare.25.2.342
Publikováno v:
Diabetes care. 25(2)
Repaglinide, a novel antidiabetic agent that has a rapid onset and short duration of action, was developed for mealtime dosing. The purpose of this pharmacodynamic study was to validate a prandial regimen of repaglinide by comparing meal-related dosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f613771d94d262e92dc23d8e472cd6eb
https://pubmed.ncbi.nlm.nih.gov/12145270
https://pubmed.ncbi.nlm.nih.gov/12145270